Shenzhen New Industries Biomedical Engineering Co Ltd
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
28 / 236
Position in country
1165 / 7387
Return on Assets, %
22.1
1.6
Net income margin, %
43.7
2.7
EBITDA margin, %
52.3
10.2
Debt to Equity, %
0
13.9
Intangible assets and goodwill, %
2
2.7
Revenue CAGR 3Y, %
21.4
11.3
Total Equity change 1Y, %
14.5
-0.3
Revenue Y, % chg
22.3
0
P/E
31.2
25.8
P/BV
6.8
1.5
P/S
13.1
2.8
EV/S
12.2
2.5
EV/EBITDA
27.2
9
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
27.7
36.5
Forward P/E
22.7
18.3
Dividend Yield, %
1
2
Forward Dividend Yield, %
0.2
0.2
Expected dividend per share
0.1
0
Payout Ratio, %
47.5
32.2
Competitors
Ranks
-
Shanghai MicroPort Endovascular MedTech Group Co Ltd
00%
-
Shenzhen New Industries Biomedical Engineering Co Ltd
00%
-
Winner Medical Co Ltd
00%
-
Micro-Tech Nanjing Co Ltd
00%
-
Autek China Inc
00%
-
Autobio Diagnostics Co Ltd
00%
-
Eyebright Medical Technology Beijing Co Ltd
00%
-
Shandong Weigao Group Medical Polymer Co Ltd
00%
-
Shandong Pharmaceutical Glass Co Ltd
00%
-
Intco Medical Technology Co Ltd
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
China
Sector
Health Care
Industry group
Health Care Equipment & Services
Industry
Health Care Equipment & Supplies
Sub-sector
Health Care
Capitalization (millions of $)
7144.6
Ticker
300832.SZ
ISIN
CNE100003T39
IPO date
2020-05-12
Availability on Russian exchanges
No
Reporting for
2024-04-11
Date fact. publication of reports
2023-12-31
Company Description
Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic chemiluminescence immunoassay analyzer series products and Biossays automatic biochemical analyzer series products. Reagents segment operates the sales of supporting reagents for the analyzers. The products are applied in the examination of Gonads, thyroid gland, glucose metabolism, kidney function and so on. Accessories and Others segment is responsible for the manufacturing and sales of accessories related to in-vitro diagnostics equipment. The Company sells its products both in domestic and international markets, including Asia, Europe, America and Africa.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: